Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals, Inc. Announces Fiscal Year 2014 First Quarter Conference Call on Thursday, August 15, 2013
August 13, 2013 11:59 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Aug. 13, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral sustained and...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals, Inc. Appoints Nasrat Hakim as President and Chief Executive Officer
August 05, 2013 07:00 ET | Elite Pharmaceuticals, Inc.
Elite Adds Twelve Approved Products to Its Pipeline Conference Call Scheduled for 1 PM Eastern Time NORTHVALE, N.J., Aug. 5, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP)...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2013, FQ4/13 Revenues Highest in Corporate History
June 21, 2013 13:44 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., June 21, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral abuse-resistant...
TAGI Pharma Announces Exclusive Marketing Rights Agreement for Alendronate Sodium Oral Solution, 70mg/75ml x 4 Pack Unit of Use
April 30, 2013 11:22 ET | TAGI Pharma, Inc.
SOUTH BELOIT, Ill., April 30, 2013 (GLOBE NEWSWIRE) -- TAGI Pharma, Inc., a specialty pharmaceutical company and subsidiary of Precision Dose, Inc., announced today the signing of an exclusive...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals Awarded Second U.S. Patent for Abuse Resistant Drug Formulation
April 23, 2013 08:23 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., April 23, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced the issuance of U.S. Patent No. 8,425,933 entitled...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals, Inc. Secures $10 Million Funding Commitment From Lincoln Park Capital Fund, LLC
April 22, 2013 08:00 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., April 22, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today that it has entered into a $10 million common stock purchase...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals, Inc. Announces First Shipment of Generic Phentermine Capsules
April 11, 2013 08:00 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., April 11, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced the initial shipment of phentermine HCl capsules 15 mg and 30 mg...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal 2013
February 14, 2013 16:20 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Feb. 14, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral controlled release...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals, Inc. to Discuss Third Quarter Results of Operations on Monday, February 14, 2011
February 10, 2011 08:00 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Feb. 10, 2011 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral sustained and...